Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial biogenesis is the cellular process by which new mitochondria are formed, increasing both the number and mass of mitochondria within a cell. This process is essential for adapting to increased energy demands or environmental changes. Key regulators include PGC–1α/PGC–1β, NRF–1/NRF–2, and TFAM. Dysregulation is implicated in neurodegenerative disorders, metabolic syndromes, and maternally inherited mitochondrial diseases. Therapeutic strategies targeting this pathway aim to enhance functional mitochondria mass.
Therapeutic strategies aim to enhance functional mitochondria mass.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial Biogenesis.